Keyphrases
Intention-to-treat
100%
Clinical Trials
100%
Per-protocol
100%
Dual Antiplatelet Therapy
100%
Aspirin
55%
Bleeding Risk
33%
Percutaneous Coronary Intervention
22%
Monotherapy
22%
Drug-eluting Stent
22%
P2Y12 Inhibitors
22%
Ticagrelor Monotherapy
22%
Intention-to-treat Analysis
11%
All-cause Mortality
11%
Acute Coronary Syndrome
11%
Clinical High Risk
11%
Therapeutic Strategies
11%
Large Sample Size
11%
Angioplasty
11%
Stent
11%
Rate Ratio
11%
Q-wave Myocardial Infarction
11%
Coronary Intervention
11%
Per-protocol Analysis
11%
Sirolimus-eluting Stent
11%
Non-fatal
11%
Therapy Strategy
11%
Everolimus-eluting
11%
Drug-eluting Stent Implantation
11%
Optimal Duration
11%
Ticagrelor
11%
Dual Antiplatelet Therapy Duration
11%
Ischemic Risk
11%
Control Strategy
11%
P2Y12 Antagonists
11%
Superiority Trial
11%
Goldilocks
11%
Medicine and Dentistry
Intention-to-Treat Analysis
100%
Clinical Trial
100%
Antiplatelet
100%
Monotherapy
50%
Acetylsalicylic Acid
50%
Drug-Eluting Stent
30%
Ticagrelor
30%
Percutaneous Coronary Intervention
20%
All Cause Mortality
10%
Acute Coronary Syndrome
10%
Myocardial Infarction
10%
Rapamycin
10%
Everolimus
10%
Angioplasty
10%
Q Wave
10%
Treatment Duration
10%
Pharmacology, Toxicology and Pharmaceutical Science
Antiplatelet
100%
Clinical Trial
100%
Monotherapy
50%
Acetylsalicylic Acid
50%
Ticagrelor
30%
Heart Infarction
10%
Acute Coronary Syndrome
10%
All Cause Mortality
10%
Rapamycin
10%
Everolimus
10%